Institute of Molecular and Translational Medicine, Faculty of Medicine and Dentistry, Palacky University, Olomouc, Czech Republic.
Institute of Molecular and Translational Medicine, Faculty of Medicine and Dentistry, Palacky University, Olomouc, Czech Republic
Life Sci Alliance. 2022 Sep 9;5(12):e202201560. doi: 10.26508/lsa.202201560.
DNA synthesis of the leading and lagging strands works independently and cells tolerate single-stranded DNA generated during strand uncoupling if it is protected by RPA molecules. Natural alkaloid emetine is used as a specific inhibitor of lagging strand synthesis, uncoupling leading and lagging strand replication. Here, by analysis of lagging strand synthesis inhibitors, we show that despite emetine completely inhibiting DNA replication: it does not induce the generation of single-stranded DNA and chromatin-bound RPA32 (CB-RPA32). In line with this, emetine does not activate the replication checkpoint nor DNA damage response. Emetine is also an inhibitor of proteosynthesis and ongoing proteosynthesis is essential for the accurate replication of DNA. Mechanistically, we demonstrate that the acute block of proteosynthesis by emetine temporally precedes its effects on DNA replication. Thus, our results are consistent with the hypothesis that emetine affects DNA replication by proteosynthesis inhibition. Emetine and mild POLA1 inhibition prevent S-phase poly(ADP-ribosyl)ation. Collectively, our study reveals that emetine is not a specific lagging strand synthesis inhibitor with implications for its use in molecular biology.
DNA 合成的前导链和滞后链独立工作,如果单链 DNA 受到 RPA 分子的保护,细胞就能容忍在链解偶联过程中产生的单链 DNA。天然生物碱依米丁被用作滞后链合成的特异性抑制剂,可解偶联前导链和滞后链复制。在这里,通过对滞后链合成抑制剂的分析,我们表明,尽管依米丁完全抑制了 DNA 复制:它不会诱导单链 DNA 和染色质结合的 RPA32(CB-RPA32)的产生。与此一致的是,依米丁不会激活复制检查点或 DNA 损伤反应。依米丁也是蛋白质合成的抑制剂,持续的蛋白质合成对于 DNA 的准确复制至关重要。从机制上讲,我们证明依米丁对蛋白质合成的急性阻断先于其对 DNA 复制的影响。因此,我们的结果与依米丁通过抑制蛋白质合成影响 DNA 复制的假设一致。依米丁和轻度 POLA1 抑制可防止 S 期聚(ADP-核糖基)化。总之,我们的研究表明,依米丁不是一种特异性的滞后链合成抑制剂,这对其在分子生物学中的应用具有重要意义。